Acetohexamide (Dymelor)

11/16/2017 - "This led to the identification of the clinically approved anti-diabetic drug acetohexamide, which promoted clearance of UV-induced DNA damage without the accumulation of chromosomal aberrations, hence promoting cellular survival. "

07/15/1967 - "[Acetohexamide (Ordimel) in the treatment of diabetes mellitus]."
03/28/1967 - "The use of acetohexamide in the treatment of diabetes mellitus."
04/01/1965 - "THE USE OF ACETOHEXAMIDE IN THE TREATMENT OF DIABETES MELLITUS."
05/01/1964 - "ACETOHEXAMIDE--A NEW ORAL AGENT FOR CONTROL OF DIABETES MELLITUS. "
04/04/1964 - "ACETOHEXAMIDE IN TREATMENT OF DIABETES MELLITUS."

01/01/1977 - "Severe hypoglycemia in a 67-year-old black male as a result of the ingestion of acetohexamide is described. "
08/01/1967 - "Hypoglycemia due to acetohexamide. "
05/01/1967 - "[Deferred hypoglycemia induced by sulfonylurea--an additional case due to acetohexamide]."
05/01/1966 - "Prolonged hypoglycemia following acetohexamide administration. "
10/01/1977 - "Acetohexamide hypoglycemia: treatment by peritoneal dialysis."

03/01/1969 - "Long term use of acetohexamide in maturity-onset diabetes mellitus."
10/01/1966 - "The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes."
04/01/1963 - "The use of acetohexamide in stable diabetes mellitus."
01/20/1991 - "Prolonged hypoglycemia induced by acetohexamide (AH) in a patient with noninsulin dependent diabetes mellitus accompanied by primary hypothyroidism was presented. "
02/01/2012 - "Sulfonylureas, such as tolbutamide, glibenclamide or acetohexamide, form a class of orally applicable drugs used in the treatment of non-insulin-dependent diabetes mellitus."

10/01/1977 - "Acetohexamide hypoglycemia in a patient with renal failure has been successfully treated by peritoneal dialysis. "
08/01/1996 - "As a result, sulphonylurea drugs such as tolazamide, acetohexamide, chlorpropamide and glibenclamide (glyburide) are more likely to cause significant hypoglycaemia, as the metabolism of these drugs, compared with other commonly prescribed sulphonylureas, can lead to the accumulation of either the parent drug or the active metabolite in the presence of renal insufficiency. "